This report is nothing new...
Every time the publish the same results they got from similar studies for ZYKA virus, they say "100%" effective.
The stock price spikes up, then floats down lower than before.
What they don't tell you is that it will take YEARS to get FDA approval, even though it's on "fast track" status.
If this was really blockbuster news, Geovax would be over $1.00 by now, but it's not. No one cares because it's the same old news story about their results for Zyka. That's why there is no volume and many of us are waiting to exit who foolishly bought in at much higher prices.
Did you notice the 8K giving them permission to sell 66M shares on the open market???
That's why the stock never goes up!
News 
Market Data 
Discover 
